Pitogo, Mark Jasper V.
HRN: 25-69-30 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/02/2024
09/08/2024
TIV
300mg
Q6
S/P ORIF Of Mandibular Area Using Titanium
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes